This special event marks NIBSCs 40th anniversary. The symposium will provide a unique platform for cross-collaboration and discussion between industry, public sector, academia and regulators and focus on the latest thinking and opportunities arising from the new Biological Medicines.
The goal is to identify potential solutions, future work programmes and productive collaborations that overcome the key regulatory challenges and facilitate accelerated access to safe and effective biologicals.
We are delighted that Professor Dame Sally Davies, Chief Medical Officer, will be giving a keynote introductory address. The event will feature international and leading experts presenting on the four key scientific themes.
Click here to view Christian Schneider, Director of NIBSC, talking about the Symposium event and benefits of attending.
Fourth theme focusing on Advanced Therapies: Delivering the Promise
- Gene therapy: Prospects and predictions
- Cell Therapies as medicines
- Evolving gene therapy for inherited immunodeficiency
- Characterising human pluripotent stem cells: the international Stem Cell initiative and the UKSCB
We are excited to announce the attendance of the following speakers to present this theme:
Professor Mary Collins - NIBSC
Dr Sven Kili - GSK
Professor Adrian Thrasher - UCL
Professor Peter Andrews - University of Sheffield
Dr Martin Pule - UCL
attendance of 200+ delegates from the biological medicines sector in the
UK and abroad.
about the latest strategic and technical developments taking place in
biological medicines and gain insight into the regulatory challenge that they
and take the opportunity to meet key contacts, build relationships and
shape the future of the new biological medicines regulation
There will also
be the opportunity to pose questions, participate in technical discussions and
to network with peers. The symposium
networking dinner (included in ticket prices) will be held on the evening of
the 17th May 2016.